No Detail Found!

Relevance of KIM-1 and NGAL biomarkers in the diagnosis of persistent kidney failure

Author(s)
Karar Yasir Hasan Section of Medical Biochemistry, College of Medicine, University of Al-Qadisiyah,Al-Diwaniyah,Iraq
Haider Abd Jabbar Al Ammar Section of Medical Biochemistry, College of Medicine, University of Al-Qadisiyah,Al-Diwaniyah,Iraq
Abstract
Background & objective: chronic kidney disease (CKD) is a long-term condition in which the kidney function is gradually lost over time, which includes filtration of waste products and excess fluids from the bloodstream, maintaining electrolytes balance and produce hormones that regulate blood pressure and stimulate red blood cell production. The target of management for CRF (CRF) is to restrict the injury to the kidneys, usually by detection of its underlying cause. The current study aimed to detect and relate biomarker levels, such as Neutrophil Gelatinase Associated Lipocalin (NGAL) and Kidney Injury Molecule type 1 (KIM-1) in patients with CKD. Methodology: Ninety participants took part in the study between Sep 2023 and Jan 2024 through random sampling. They were divided into two groups; Group-1 included 45 healthy volunteers, and Group-2 included 45 individuals with CKD, stage 1 to end stage renal failure and were on dialysis. The ELISA method was used to measure the serum levels of NGAL and KIM-1 in each person. Colorimetric techniques were used to measure creatinine, potassium, calcium, serum urea, and random blood sugar (RBS). Version 25 of IBM's statistical software for the social sciences (SPSS) on a Windows platform was used to conduct the statistical study. Using the analysis of variance student t test, patients with CKD were compared to a healthy group; a P = 0. 05 indicated statistical significance. Results: Between individuals with chronic kidney disease and the healthy group, there was a statistically significant variance in NGAL and KIM_1, serum creatinine, urea, potassium, calcium, and RBS. Conclusion: Patients with CRF had considerably higher levels of Neutrophil Gelatinase Associated Lipocalin (NGAL) and Kidney Injury Molecule type 1 (KIM-1), which are diagnostic markers. 
Publication Details
Page(s) 472-480
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 28, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
KIM-1, NGAL, Chronic renal conditions
References
.2021 .Chronic kidney disease. Lancet, 398(10302) : 786-802.
. .. , 6736(21) : 00519-5.
Webster AC,Nagler E V,Morton RL .2017 .Chronic kidney disease. Lancet, 6736(16) : 32064-5.
.2020 .. , 66(S1) : 66-9.
.2019 .. , 322(13) : 1294-304.
CP Kovesdy .2021 .. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl, 11(1) : 7-11.
Lv JC,Zhang LX .2019 .Prevalence and disease burden of chronic kidney disease. Ren Fibros Mech Ther, 1165 : 3-15.
. .. , (2) : 1.
EF Carney .2020 .The impact of chronic kidney disease on global health. Nat Rev Nephrol, 16(5) : 251.
.2019 .Chronic kidney disease in the United States. , : .
Atlanta ,GA US Dep Health Human Serv Centers Dis Control Prev .2019 .. , : .
Gaitonde DY,Cook DL,Rivera IM .2017 .Chronic kidney disease: detection and evaluation. Am Fam Physician, 96(12) : 776-83.
.2010 .National chronic kidney disease fact sheet: general information and national estimates on chronic kidney disease in the United States. ga Us Dep Heal Hum Serv centers Dis Control Prev, : .
Gansevoort RT,Correa-Rotter R,Hemmelgarn BR,Jafar TH,Heerspink HJL,Mann JF .2013 .Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet, 6736(13) : 60595-4.
Neuen BL,Chadban SJ,Demaio AR,Johnson DW,Perkovic V .2017 .Chronic kidney disease and the global NCDs agenda. BMJ Glob Health, 2(2) : e000380-000380.
Soni SS,Cruz D,Bobek I,Chionh CY,Nalesso F,Lentini P .2010 .NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol, 42 : 141-50.
Bolignano D,Donato V,Coppolino G,Campo S,Buemi A,Lacquaniti A .2008 .Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J kidney Dis, 01(3) : 595-605.
Fassett RG,Venuthurupalli SK,Gobe GC,Coombes JS,Cooper MA,Hoy WE .2011 .Biomarkers in chronic kidney disease: a review. Kidney Int, 80(8) : 806-21.
Patel ML,Sachan R,Misra R,Kamal R,Shyam R .2015 .Prognostic significance of urinary NGAL in chronic kidney disease. Int J Nephrol Renovasc Dis, : 139-44.
Steinbach S,Weis J,Schweighauser A,Francey T,Neiger R .2014 .Plasma and urine neutrophil gelatinase-associated Lipocalin (NGAL) in dogs with acute kidney injury or chronic kidney disease. J Vet Intern Med, 28(2) : 264-9.
Buonafine M,Martinez-Martinez E,Jaisser F .2018 .More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases. Clin Sci, 132(9) : 909-23.
Jasotani K,Dahiya K,Ahlawat R,Gupta M,Kumar S,Dhankhar R .2022 .. NGAL: An Upcoming Biomarker of Interest. Indian J Med Biochem, 10054(1) : 27.
Collins AJ,Pitt B,Reaven N,Funk S,McGaughey K,Wilson D .2017 .Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes. Am J Nephrol, 46(3) : 213-21.
Yin C,Wang N C .2016 .Kidney injury molecule-1 in kidney disease. Ren Fail, 38(10) : 1567-73.
Huo W,Zhang K,Nie Z,Li Q,Jin F .2010 .Kidney injury molecule-1 (KIM-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. Transplant Rev (Orlando), 02(3) : 143-6.
Bonventre JV .2009 .Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant, 24(11) : 3265-8.
Boettner B. .2013 .KIM-1 driving chronic kidney disease. ScienceBusiness eXchange, 10 : 1085.
McMillan R,Skiadopoulos L,Hoppensteadt D,Guler N,Bansal V,Parasuraman R .2018 .Biomarkers of endothelial, renal, and platelet dysfunction in stage 5 chronic kidney disease hemodialysis patients with heart failure. Clin Appl Thromb Hemost, 24(2) : 235-40.
Schmidt IM,Srivastava A,Sabbisetti V,McMahon GM,He J,Chen J .2021 .Plasma kidney injury molecule 1 in CKD: findings from the Boston Kidney Biopsy Cohort and CRIC studies. Am J Kidney Dis, 05(2) : 231-43.
Li L,Luo S,Hu B,Greene T. .2017 .Dynamic prediction of renal failure using longitudinal biomarkers in a cohort study of chronic kidney disease. Stat Biosci, 9 : 357-78.
Schrezenmeier E V,Barasch J,Budde K,Westhoff T,SchmidtOtt KM .2017 .Biomarkers in acute kidney injury-pathophysiological basis and clinical performance. Acta Physiol, 219(3) : 554-572.
.2010 .Neutrophil gelatinase‐associated lipocalin: A troponin‐like biomarker for human acute kidney injury. Nephrology, 01317(4) : 1797-28.
Seibert FS,Sitz M,Passfall J,Haesner M,Laschinski P,Buhl M .2018 .Prognostic value of urinary calprotectin, NGAL and KIM-1 in chronic kidney disease. Kidney Blood Press Res, 43(4) : 1255-62.
eibert FS,Sitz M,Passfall J,Haesner M,Laschinski P,Buhl M .2021 .Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases. Ren Fail, 43(1) : 417-24.
0

Citations

0

Downloads

38

Views